Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2019 | Story Xolisa Mnukwa
Geben van Niekerk
Gerben van Niekerk was recognized as a Bright Star at this year's Liberty Radio Awards.

In 2019, Kovsie FM was recognised by the Liberty Radio Awards as one of the radio stations that secures the future of the radio industry by employing excellence and motivating the consistent raising of standards. 

The Liberty Radio Awards is a transparent awards programme that promotes and highlights excellence by recognising and honouring South Africa’s outstanding radio talent, from in-front-of-the mic presenters to behind-the-scenes producers. The awards have the objective of ensuring that radio remains one of the country’s leading media choices.

The station was nominated in categories including the Best Community Project for the Kovsie FM Cool Kid takeover initiative, and the 2019 Bright Star award, of which University of the Free State (UFS) Student Media Manager and OFM Before Dawn radio presenter, Gerben van Niekerk, was inaugurated as one of the 2019 Liberty Radio Awards Bright Stars. 

Thabang Moselane, UFS alumnus, former OFM radio anchor on A Touch of Thabang, social-media manager for online publication, The Journalist, and freelance researcher, writer, and director for a Johannesburg-based film production company, was also recognised and inducted as a Bright Star at the 2019 Liberty Radio Awards.

2019 Liberty Radio Awards’ Bright Star winner, Van Niekerk, explained that the essence of his job at Kovsie FM is to ensure that the student talent that is produced and groomed in their studios daily, morphs into an array of folk who possess the unquestionable skill and aptitude that is widely sought in commercial South African radio.

A great testimony of Van Niekerk’s mission for Kovsie FM, is former Kovsie FM presenter, Smash Afrika, who has moved on to hosting Live at Night on 5FM, and co-presenting Massive Music on Channel O, and Mzansi Magic with Lalla Hirayama. Former station programme manager, Sam Ludidi, is another gem that was cultivated through Kovsie FM, and now works as rugby presenter on SuperSport TV, and also forms part of the OFM team. 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept